Neurofeedback Systems Market by 2027 With Technological Advancements, Segmentation, Growth Of Industry, Overview and Dynamics with Affecting Factors

Neurofeedback Systems Market: Overview

Global neurofeedback systems market is oligopolistic in nature with few players dominant in the marketplace. Marketers in the neurofeedback systems market is coming up with newer technologies and training modules for healthcare professionals to garner larger market share. Neurofeedback system is a reimbursable service in developed economies which helps in increased adoption of this method of treatment.

Neurofeedback system is a non-invasive type of direct brain function training. Neurofeedback is a type of biofeedback and therefore it is called as EEG biofeedback. Neurofeedback uses the electrodes to record and amplify the brain waves. Neurofeedback system controls the visual, auditory and tactical feedback which helps learning to take place. Neurofeedback system enhances relaxation and initiates the self-regulation, both are necessary components of good brain function. Neurofeedback system takes into account of behavioural, cognitive, and subjective aspects as well as brain activity to better map the brain activity. The International Society for Neurofeedback and Research (ISNR) defines biofeedback as “a process that enables an individual to learn how to change physiological activity for the purposes of improving health and performance.

Neurofeedback Systems Market: Drivers and Restraints

Global neurofeedback systems market is continue to witness positive growth owing to its alternative and complementary treatment for several brain dysfunction, rising demand for non-invasive treatment protocols and increased prevalence of several neurological disorders in the recent times would expected to fuel demand neurofeedback systems over a period of forecast. The market neurofeedback systems driven by increasing technological advances in the neurofeedback system and rising product approval pipeline expected to fuel the market for Neurofeedback Systems over a period of forecast. However, neurofeedback system is expensive, results often time consuming, benefits are not long lasting, dearth of skilled professionals to operate the systems and lack of conclusive scientific evidence may hamper the growth of the neurofeedback systems market over a period of forecast.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-3447

Neurofeedback Systems Market: Region-wise Outlook

Geographically, neurofeedback systems market is segmented into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America and Europe will remain key markets for neurofeedback systems market. Developed markets like North America and Europe is expected to witness robust growth owing to advanced healthcare infrastructure, reimbursement policies in the region. Moreover, key players in theneurofeedback systems market are majorly focusing on both developed and developing regions markets to tap the market share. Asia Pacific is anticipated to register positive growth owing to favourable patient demographics and rising healthcare awareness in the region.

Neurofeedback Systems Market: Key Players

Some players in neurofeedback systems market include BrainMaster Technologies, Inc., bee Medic, brainquiry, Mitsar Co. Ltd., Thought Technology Ltd., Mind Media B.V., Wearable Sensing to name a few.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil and Rest of Latin America)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg and Rest of Western Europe)
  • Eastern Europe (Poland, Russia and Rest of Eastern Europe)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, and Rest of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Neurofeedback Systems Market: Segmentation

Global neurofeedback systems market has been segmented on the basis of product, type of neurofeedback system, application, end user and region

Based on the product type, the global neurofeedback systems market is segmented into the following:

  • Amplifiers
  • Electrodes or Sensors
  • Computer Software

Based on the neurofeedback system type, the global neurofeedback systems market is segmented into the following:

  • Frequency/Power Neurofeedback System
  • Slow Cortical Potential Neurofeedback (SCP-NF) System
  • Low-Energy Neurofeedback System (LENS)
  • Hemoencephalographic (HEG) Neurofeedback System
  • Live Z-Score Neurofeedback System
  • Low-Resolution Electromagnetic Tomography (LORE-TA)
  • Functional Magnetic Resonance Imaging (fMRI)

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-3447

Based on the application, the global neurofeedback systems market is segmented into the following:

  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Anxiety
  • Depression
  • Epilepsy
  • Insomnia
  • Drug Addiction
  • Schizophrenia
  • Others

Based on the end user, the global neurofeedback systems market is segmented into the following:

  • Hospitals
  • Physician Offices
  • Ambulatory Surgical center

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

BRICS Oral Care Market Insights, Deep Analysis of Key Vendor in the Industry 2022-2031

An up to date study by Future Market Insights (FMI) has detected that the competition in the oral care market in BRICS countries is intense, although a few companies such as Uniliver Group, Colgate-Palmolive Co., Koninklijke Philips N.V., Procter & Gamble Co., Johnson & Johnson Inc., and GlaxoSmithKline Plc. do hold a position of strength and are expected to maintain their strong position in the near future too. For most of these companies, development of new and innovative products and aggressive marketing activities are common strategies to lure consumers and retain them in a long run. The growing trend of organic products is also opening new opportunities for the vendors to impress the urban populations and gain new revenue avenues.

As per the projections of the FMI report, the demand in global oral care market will expand at a CAGR of 4.5% during the forecast period of 2014 to 2020, representing a revenue of US$50.8 bn by 2020. However, the BRICS oral care market is in much healthier position with the demand projected to increment at nearly double CAGR of US$8.4% during the same forecast period. The report has estimated that the BRICS nations will constitute for a demand for oral care products worth of US$17.3 bn by 2020. This report targets audiences such as dental product manufacturers and distributors, dental research and development institutes, government associations and dental practitioners, and venture capitalists and investors.

The report observes that with increased disposable income of the urban populations in BRICS countries, viz. Brazil, Russia, India, China, and South Africa, consumers are now willing to pay for a variety of products that helps them keep their oral and respiratory systems healthy. Ubiquity of smartphones and growing popularity of social media has helped pass on the awareness to large masses and is providing traction to the BRICS oral care market. In addition to that, introduction of oral care products that are ecofriendly and made up from organic ingredients are gaining demand. Growing awareness among consumers for oral hygiene is another factors fueling the demand in this market.

Toothpaste Most Profitable Product Segment

On the basis of product type, the oral care market in the BRICS countries is segmented into primary oral care including toothbrush and toothpaste and secondary oral care including dental floss, mouthwash, denture care, and others such as whitening strips, chewing gum, and mouth fresheners. Currently, primary oral care sub-segments collective account for the most prominent chunk of demand, with toothpaste producing the maximum demand. Gel toothpaste, sensitivity-resistant toothpaste, and gum strengthening toothpaste are a few new products attracting specific customers. On the other hand, the demand for secondary oral care products is projected to increment at a strong CAGR of 14.5% during the forecast period of 2014 to 2020, gaining traction from the introduction of new products in this segment.

Based on distribution channel, the BRICS oral care market has been bifurcated into departmental stores, convenience stores, hypermarkets and supermarkets, vending machines, pharmacies and specialty stores, direct selling, and general merchandise retailers. In 2013, the general merchandising and direct selling segments collectively accounted for 53% of the overall demand, while hypermarkets and supermarkets provided for 27% of the demand.

Country-wise, heavily populated countries of India and China currently produce the most prominent chunk of demand and are anticipated to further gain demand share as we approach 2020. These two countries served 50.6% of total demand in the BRICS oral care market in 2014 and the demand percentage is estimated to increase up to 52.7% by 2020.

Request Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep–27

Key Segmenton the basis of product type

  • primary oral care products
    • ?toothbrush
      • ?specialised
      • mid-tier
      • kids
    • toothpaste
      • ?gel toothpaste
      • non-gel toothpaste
  • secondary oral care products
    • ?mouthwash
      • ?comprises flavoured
      • conventional
      • organic toothpaste
    • dental floss
      • ?waxed
      • unwaxed
      • flavoured
      • unflavoured
      • thread
      • tape floss
    • denture care
      • ?denture care products
        • ?cleanser
        • adhesive
        • paste
      • denture care fixtures
        • ?complete
        • partial
        • over denture fixtures
    • others

on the basis of product type

  • convenience stores
  • department stores
  • direct selling
  • general merchandise retailers
  • hypermarkets & supermarkets
  • vending machines
  • speciality stores & pharmacies
  • direct selling
  • others

Pharmacy And Drug Store Franchises Market Market 2021 Industry Insight and Growth Strategy by Business Players and Forecast To 2026

We all need to visit a pharmacy or drug store at least occasionally due to an injury, disease or just to stock up on vitamin & other supplements. The Pharmacy & Drug Store Franchises market consists of neighbourhood pharmacies, large domestic or global drug store chains, supermarkets, retailers with specific drug store departments and various pharmacy chains.  The Pharmacy & Drug Store Franchises market serves its clients a range of prescription & over-the-counter medicines, toiletries, beauty products & other forms of consumable goods. The players involved in this industry are not independent but exactly like other retailers that operate under franchise agreements. The terms & conditions specified in the franchise agreement govern how these stores operate.  While drug stores & pharmacies are ubiquitous, the competition in the industry is extremely intense as retailers have to adapt to rapidly changing trends around the world and seek to enhance customer loyalty. There has been rapid growth in the 21st century in the Pharmacy & Drug Store Franchises market.

Gain complete access to the report @ https://www.futuremarketinsights.com/reports/pharmacy-and-drug-store-franchises-market

Pharmacy & Drug Store Franchises Market Drivers

A critical driver for the Pharmacy & Drug Store Franchises market is the widespread adoption of generic drugs. These drugs are identical to branded drugs in dosage, safety, strength, method of administration, characteristics & purpose of use. The main benefit is that they are substantially cheaper than the latter. As per the U.S Congressional Budget Office, generic drugs can save patients anywhere between $8 & $10 billion a year. A second driver is the fact that pharmacy & drug stores are essentially a basic need of humanity. Health-related expenditure will only go up across the world as more & more people get access to better medical care. An ageing population in developed countries, youth with sports related injuries, or working professionals suffering from clinical depression, stress, diabetes or hypertension will all be dependent on the Pharmacy & Drug Store Franchises market. Another major factor is the medical education industry. Pharmacy schools, in particular, are responsible for the resurgence in their franchises. Medical schools tend to provide their students only specialised knowledge with very little business or management skills. Pharmacists can make good money opening franchises which also help them pay off their massive student loans. These are anticipated to be the main drivers of the Pharmacy & Drug Store Franchises market in the next decade.

Pharmacy & Drug Store Franchises Market Restraints

There are some challenges to be overcome in the Pharmacy & Drug Store Franchises market. A major one is the cost of pharmacy-based managers which have been rising. PBM’s oversee drug-benefit plans of both the employers & health insurers. Their main purpose is to keep the cost steady, which they accomplish by deciding which drugs to cover & then securing lower prices from drug makers through rebate programs. Since these are based on a percentage cut, PBM’s have benefited from skyrocketing drug prices. There is also intense competition as incumbent players resort to a price war to drive out new players with limited funds. Not only does this reduce the overall industry profitability, but it also makes fledgling companies hesitant to enter the Pharmacy & Drug Store Franchises market.

Pharmacy & Drug Store Franchises Market Key Regions

The largest Pharmacy & Drug Store Franchises market in the world are the U.S, China, Japan, the E.U and the rest of the world in that order. The U.S is expected to maintain their sizeable lead over other countries on account of a large population segment being aged 65 and over, high disposable income, and government funding for Medicare and Medicaid. China is anticipated to become the largest within the next decade or so on account of their massive population and government focus on the healthcare industry as a whole. This will thereby also benefit the regional Pharmacy & Drug Store Franchises market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-2454

Pharmacy & Drug Store Franchises Market Key Market Players 

Some companies in the Pharmacy & Drug Store Franchises market are MedPlus, Medzone, Medicap, Apollo Pharmacy, Discount Drug Stores, RK Franchise Consultancy, CVS, Rite Aid, Walgreens, & Shopper’s Drug Mart.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, types and applications.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Pharmacy And Drug Store Franchises Market

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2454

Traumatic Brain Injuries Treatment Market Analysis, Recent Trends and Regional Growth Forecast by 2027

Each year traumatic brain injuries (TBI) contribute a substantial number of cases worldwide. TBI can be defined as an injury to the brain resulting from externally inflicted trauma resulting in damage to the brain cells and blood vessels. The signs and symptoms of TBI may appear soon after the head trauma or may sometimes take several days to weeks to appear. TBI can be categorized as mild, moderate and severe brain injury. In case of a mild injury a patient experiences a brief concussion and in rare situations may lead to lasting functional brain changes. However, the risk of developing severe and permanent brain damage increases with the extent and severity of the traumatic brain injury and the level of unconsciousness. Depending up on the location of the injury,  TBI can lead to dementia along with memory, lack of concentration, problems related with speech and eating, lack of coordination and walking problems are often associated with moderate to severe brain injuries. As estimated by Center for Diseases Control and Prevention (CDC) every day 138 people in the U.S. die from TBI. According to the CDC 2010 estimates in the U.S. approximately 2.5 million emergency department visits and hospitalization were associated with TBI cases (either alone or in combination with other injuries).  Falls are leading cause of hospitalization in patients with TBI followed by accidents including motor, vehicle traffic injuries.

Mild traumatic brain injuries do not require treatment other than over the counter pain relievers and the patient with mild traumatic injury need not to be monitored in hospital.  However for treatment of severe TBI several medications indicated includes several diuretics, anti- seizure drugs, comma inducing drugs etc. However, in case of severe TBI surgery and rehabilitation is required. The traumatic brain injuries treatment market is expected to witness higher growth over the forecast period owing to introduction of several new therapies. Increasing number of manufacturers are developing new medications for the treatment of TBI and large number of clinical trials are conducted in order to better understand the etiology of the condition.

Traumatic Brain Injuries Treatment Market: Drivers & Restraints

Extensive R&D by U.S. Food and Drug Administration (FDA) scientists in order to study various biomarkers of brain imaging, bio fluid and physical indicators such as eye tracking and electroencephalography holds immense potential as diagnostic techniques for detection of TBI. This is expected to change the treatment pattern of TBI in patients with severe brain injuries. Apart from this a large number of clinical trials are conducted worldwide in order to develop effective therapies for TBI have proven to be opportunistic for the market growth of TBI treatment in the near future. Furthermore rising incidence of falls cases along with accidental cases are expected to be the leading accelerating factors for market growth of TBI treatment market globally. The expected entry of some molecular targeted therapies such as BHR-100, a progesterone drug being developed by BHR Pharma, LLC,  rhuEpo, a recombinant human erythropoietin are expected to brace the TBI treatment market growth over the forecast period. However, factors such as low societal awareness, delayed diagnosis and low government funding in TBI treatment research are expected to hamper the TBI treatment market growth in the future.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-2678

Traumatic Brain Injuries Treatment Market: Overview

The traumatic brain injury treatment market is expected to increase at an alarming rate among children’s and adults over the forecast period. In children’s, few outcomes of TBI may not be encountered at an initial stage of but can emerge in later developmental stages of his/her life which may lead to chronic behavior problems and  social isolation. Better understanding of the injury mechanisms and its effect on sub-populations is required in order to manage the TBI. Growing number of falling cases and accidental cases worldwide are expected to drive revenue growth of TBI treatment in the near future.

Traumatic Brain Injuries Treatment Market: Region-wise Outlook

On the basis of region presence, traumatic brain injuries treatment market is segmented into seven key regions: North America, Latin America, and Eastern Europe, Western Europe, and Asia pacific excluding japan, Japan, Middle East and Africa. The incidence of TBI is higher in regions such as Asia Pacific, North America and Western Europe. TBI is the major cause of mortality accounting for 30% of all death related injuries in the U.S. Presence of several pipeline therapies in treatment of TBI is expected to be the biggest driver in global TBI treatment market. Cognosci, a privately held U.S. start-up is developing a novel therapeutic compound, COG1410, for the treatment of TBI which is expected to launch in the coming years.

Traumatic Brain Injuries Treatment Market: Key Players

Some of the key market players in the traumatic brain injuries treatment market are, Zimmer Biomet, Neuren Pharmaceuticals Ltd., Oxygen Biotherapeutics Inc, TEVA Pharmaceutical Industries Ltd., Ischemic,  Grace Laboratories LLC. Several key players developing therapeutics for TBI treatment include, Cognosci, Medicortex, Amarantus BioScience Holdings, Aldagen, NeuroScience Pharmaceuticals and Targacept.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Value Chain

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2678

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Traumatic Brain Injuries Treatment Market: Segmentation

Traumatic Brain Injuries Treatment marketis segmented by treatment type, route of administration, end user and geography:

By Treatment Type

  • Drugs
  • Analgesics
  • Anti-Anxiety Agents
  • Anti-Coagulants
  • Anti-Convulsants
  • Anti-Depressants
  • Anti-Psychotics
  • Others
  • Surgery

By Route Of Administration

  • Oral
  • Injectable

By Distribution Channel

  • Hospital Pharmacies
  • Drug Stores
  • Independent Pharmacies

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-2678

Dental Services Market Industry Analysis, Opportunities, Technology, Demand, Top Players and Growth Forecast 2026

Rapidly increasing dental awareness campaigns has been witnessed as a trend gaining significant traction in dental services market since the recent past. Tie-ups between print media and visual media for supporting promotion of importance of dental health checkup is expected to create significant growth avenues for dental services market. Growing incidences of dental diseases, rising geriatric population and availability of well-established healthcare infrastructure is expected to augment the demand and supply of dental services. However, increasing focus on development of the dental vaccines that helps in prevention of dental diseases has been significantly restraining the growth of dental services market.

Laser dentistry is likely to gain significant traction in dental services market owing to the benefit this service offers by eliminating the need for usage of surgical instruments. Dental clinics is anticipated to be the end-user holding lion’s share in dental services market. Rising mergers and collaborations between insurance companies and dental clinics is expected to create positive growth aspects for dental services market.

Large population base and rising government initiatives is expected to offer favorable growth prospects for dental services market in developing countries. Dental services market is anticipated to experience a transformation in their delivery model with the help of dental support organizations that are leading to rising group or corporate practices.

Dental services is one of the fastest growing market in the healthcare industry. Dental services include diagnosis, prevention and treatment of diseases of oral cavity. Dental services include dental implants, root canal – endodontic, cosmetic dentistry, oral surgery, laser dentistry, dentures and smile makeover.

General oral cavity diseases include, dental caries also known as tooth decay and pyorrhea are expected to boost the Dental services market. Dental services treatments include, extraction or surgical removal of teeth, restoration of teeth, scaling and root planning and endodontic root canal treatment.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-1440

In the U.S. around 90% of young population have dental caries, while out of all dentate adults almost 94% have evidence of coronal caries. According to Centers for Disease Control and Prevention (CDC) report 47.2% of the total population in the U.S. who are above 30 years suffers from periodontal disease.

Dental Services Market: Drivers and Restraints

Rising number of people suffering from periodontal disease, growing private health insurance coverageis and escalating demand for cosmetic and elective dentistry are factors driving the growth of dental services market.Factors contributing in the growth of dental services market are increased proportion of sugar based medication and existing life style factors. Additionally, the increasing population in the Asia Pacific region is also the major factor to drive the growth of global dental services market. However, according to WHO, it was observed that the cases with dental caries are declining due to the number of public health measures and improved self-care practices in the developed countries. These are the major restraints for the dental services market.

Dental Services Market: Overview

Increasing healthcare awareness among mass population along with rise in prevalence rate of oral cavity diseases expected to propel the overall demand for dental services worldwide. Increased focus on personal appearance and improvements in technology, materials, and methods are spurring demand for cosmetic and elective dental services. The market is expected to witness a healthy growth over the forecast period (2016-2026)

Dental Services Market: Region- wise Outlook

Depending on geographic regions, the global Dental services Market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa.

North America dominates the global market for dental services market due to high prevalence rate of dental caries, followed by Europe. According to WHO, 90% people are diagnosed with dental caries in North America. Asia & pacific regions is expected to record a healthy growth rate in a CAGR due to people adopting to smile makeover treatment.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1440

Dental Services Market: Key Players

Some of the key players in this market are

  • Apollo White Dental
  • Dental Services Group
  • Pacific Dental Services
  • Great Expressions Dental Centers
  • Gentle Dentistry, LLC
  • Coast Dental Services, LLC

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Dental Services Market: Segmentation

Dental services market is segmented into following types

By Service

  • Dental Implants
  • Orthodontics
  • Periodontics
  • Root Canal – Endodontics
  • Cosmetic Dentistry
  • Laser Dentistry
  • Dentures
  • Oral and Maxillofacial Surgery
  • Smile Makeover

End User

  • Hospitals
  • Dental Clinics

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-1440

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Hospital Capacity Management Solutions Market expected to grow at 5% CAGR through 2030

FMI, an ESOMAR-certified market research firm, states that the global hospital capacity management solutions market will reach US$ 994 Mn in 2020, growing at 5% y-o-y in 2020.

Adoption of hospital capacity management solutions is seen amongst large patient care facilities for rendering a smooth workflow in terms of downtime as well as cost. This factor is expected to drive the hospital capacity management solutions market in the forecast period.

Hospital Capacity Management Solutions Market Outlook & Key Findings

  • Global hospital capacity management solutions market expected to grow at 5% CAGR through 2030
  • RTLS (Real time locating system) preferred capacity management solution among end users
  • Cloud-Based hospital capacity management solutions gaining adoption
  • Manufacturers focusing on the introduction of integrated hospital capacity management solutions to have multiple solutions in one go
  • North America and Europe collectively account for more than half of the hospital capacity management solutions market and would continue to do so during the forecast period

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1013

Hospital Capacity Management Solutions: Adoption Amidst COVID-19 Pandemic

The outbreak of Covid-19 has resulted into growing adoption for hospital capacity management solutions. The patients’ records maintained herein help in administering the course of treatment, especially if they test positive for Covid-19.

Besides, wireless access to this data helps in taking precautionary measures in sensitive areas. The other advantages include patient discharge management, patient flow optimization, supply chain management, and bed capacity management.

hospital capacity management solutions sector region wise plc position and notable trends

High Cost of Hospital Capacity Solutions: A Key Challenge

Hospital capacity management solutions have gained popularity in the developed countries. However, adoption of these services in developing regions continues to be low.

Plus, poor healthcare infrastructure herein is posing a challenge to the adoption of hospital capacity management solutions. Some of hospital management software’s include MocDoc, Insta, Attune, eHospital, and ITDose Infosystem.

Market Research Methodology – Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Major Leading Players :

Several manufacturers are looking to make an entry to the hospital capacity management solutions market with introduction of digitization and integrated solutions. Some of the key players in the hospital capacity management solutions market are:

Americas

  • Cerner Corporation
  • Epic Systems Corporation
  • TeleTracking Technologies, Inc.
  • Sonitor Technologies, Inc.
  • STANLEY Healthcare
  • Allscripts
  • McKesson Corporation

Europe

  • Arcomed AG
  • Koninklijke Philips N.V.

Asia Pacific

  • JVS Group
  • Infosys Limited
  • Neusoft Corporation
  • INFINITT Healthcare Co. Ltd.

*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-1013

Key Takeaways of Hospital Capacity Management Solutions Market Study

  • RTLS (Real time locating system) accounted for around 34% of hospital capacity management solutions market in 2019 and is expected to continue with being top-seeded in the forecast period
  • Cloud-based hospital capacity management solution contributed for around 3/5th of market value share in 2019
  • Cumulatively, North America and Europe contributed for more than 70% of the total share of the hospital capacity management solutions market in 2019
  • Countries such as Brazil, China, South Africa, and India are expected to are emerging as lucrative markets, but pale in comparison to US and Europe

Expansive Prominence in the hospital capacity management solutions market

Taking the expansive way of growth helps in strengthening the solutions’ and software’s portfolio; as e-Health has picked up pace looking at the accuracy and need for data management.

  • STANLEY Healthcare, in May 2020, announced the assimilation of AeroScout Real-Time Location System (RTLS) with certification from Cisco DNA Spaces. The objective of this move is to table economic solution across the healthcare industry
  • Allscripts has its “2bPrecise” platform that takes in clinical information from the EHR preferred by client along with genomic/genetic data from the molecular labs, thereby giving a comprehendible patient record. This gives precise diagnoses at a faster rate.
  • TeleTracking Technologies have their Capacity Management Suite with PreAdmitTracking with electronic bedboard to enable patient access as well as placement

Hospital Capacity Management Solutions Market: Segmentation

The global hospital capacity management solutions is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Product Type

  • Workflow Management Solutions
  • Asset Management Solutions
  • Bed Management Solutions
  • Quality Patient Care Solutions
  • Real Time Locating System (RTLS)
  • Event Driven Solutions
    • Online Registration Solutions
    • Attendance Management Tools
    • Event Driven Patient Tracking
    • Others

Application

  • Standalone Solutions
  • Integrated Solutions

Delivery Mode

  • On Premise
  • Cloud-Based

Regions

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa (MEA)

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1013

Contrast Media Injectors Market estimating global revenues to grow at 4.9% CAGR through 2030

[270] Pages Report] FMI, an ESOMAR-certified market research firm, estimates global contrast media injectors market revenues to reach US$ 1.2 Bn in 2020. In its new study, FMI takes a long-term optimistic view of the market, estimating global revenues to grow at 4.9% CAGR through 2030. The report opines that AI’s growing penetration in the healthcare sector will also rub off on contrast media injectors industry during the next decade.

Key Takeaways of Contrast Media Injectors Market Study

  • North America is expected to be the most lucrative region and account for more than 32% of revenue in the global contrast media injectors in 2020 and this trend is expected to continue during the forecast period
  • Larger patient pool and increasing government support towards developing healthcare system in Asian countries are expected to propel the growth of the contrast media injectors market in the region
  • AI is expected to speed up the process of injecting contrast media in the forecast period
  • Increasing applications in orthopedic surgeries and neurosurgeries to bolster the market in the forecast period

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-823

Contrast Media Injectors Market Outlook & Key Findings

  • Contrast media injectors market likely to grow at over 4.9 % through 2030
  • The rising cost of contrast media injectors is expected to hamper the market growth as most small- and medium-sized hospitals cannot afford them
  • Extensive research regarding biodegradable contrast media injectors to drive investment in the near future
  • Unhealthy lifestyle to propagate the use of contrast media injectors in the upcoming period

contrast media injectors market key region and type analysis

Leading Players in Contrast Media Injectors Market

The contrast media injectors market players are trying out every possible mode of organic/inorganic growth to sustain themselves in the market. For instance – Windsong Radiology Group acquired MEDRAD Stellant FLEX Injection System to help both – Windsong and Bayer to avert downtime, standardize care, and minimize operational costs.

Shenzhen Anke High-tech Co. Ltd.’s single-head CT SCAN contrast media injector is endowed with injection interruption that facilitates flexible handling of emergencies. Contrast media injectors offered by Ulrich GmbH & Co. KG facilitate user-friendly handling and have been into the market since the last 3 decades with use in MRI and CT.

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-823

The above-mentioned players along with the others in the contrast media injectors market include:

Americas

  • Mallinckrodt (Guerbet SA)
  • GE Healthcare

Europe

  • Bayer AG
  • Ulrich GmbH & Co. KG
  • Bracco Imaging S.p.A
  • Medtron

Asia Pacific

  • Nemoto Kyorindo Co. Ltd
  • Shenzhen Anke High-tech Co. Ltd

*The list is only for representational purposes not exhaustive. Full competitive intelligence with SWOT analysis available in the report

New Product Launches and Approval – The Ongoing Trend

The market players are into getting their new products launched as well as approved to stay in the competition and also keep pace with the market scenario (that of continuing to innovate). The constructive steps in this regard are:

  • In Apr 2020, Guerbet announced getting approved by the US FDA for manufacturing gadoterate meglumine (Dotarem) injection inside the US. Till late 2019, this production used to happen outside of the US.
  • In Nov 2019, the US FDA approved an MRI contrast agent “Clariscan” for intravenous use in spine, brain (intracranial), and associated tissues.
  • In Aug 2019, Bracco Diagnostics, Inc. announced getting approved by the US FDA for oral suspension of barium sulfate (Varibar Thin Liquid). The basic use of this contrast agent is detection and assessment of dysphagia.

What else is in the report?

Future market insights offer actionable insights and unique perspective on contrast media injectors market in its latest study, presenting historical demand assessment from 2015 – 2019 and projections from 2020–2030 based on product type (angiographic injectors, magnetic resonance imaging (MRI) injectors, computed tomography (CT) injectors), by end-user (hospital, ambulatory surgical centres, diagnostics centres) in seven key regions

Key Segments of Contrast Media Injectors Market

FMI’s study on the contrast media injectors market offers information divided into three important segments— product type, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product Type

  • Angiographic Injectors
  • Computed Tomography (CT) Injectors
  • Magnetic Resonance Imaging (MRI) Injectors

End User

  • Hospital
  • Ambulatory Surgical centers
  • Diagnostics Centers

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-823

Ophthalmic Diagnostic Equipment Market will increase from 126.6 Million to 191 Million by 2030

As per NCBI, the number of people suffering from diabetic retinopathy will increase from 126.6 Mn in 2010 to 191 Mn by 2030. It also states that VTDR (Vision-threatening Diabetic Retinopathy) will witness an increase from 37.3 Mn to 56.3 Mn in the same period.

The above-mentioned figures, coupled with an influx of ophthalmic diagnostic centres in the countries like India and China (homes to the 2 top-seeded diabetic patients) are expected to drive the ophthalmic diagnostic equipment market in the forecast period.

Plus, the reimbursement scenario regarding eye care treatment is improving in developed and developing countries alike. Initially, reimbursement was possible only if there was a hospital stay for at least 24 hours.

However, the present scenario is such that LASER technology enables single-day treatment and insurance coverage is applicable therein. So, people in low-income countries will also not shy away from availing eye care treatments.

Ophthalmic Diagnostic Equipment Market Segmentation by Product

Key players

Key market players covered in this report are TOPCON CORPORATION, Carl Zeiss Vision International GmbH, Ellex, Quantel Medical Inc, NIDEK CO., LTD, HAAG-STREIT GROUP, Halma plc, Coburn Technologies Inc. and Kowa Company Ltd. Major players in the ophthalmic diagnostic equipment market focus on enhancing their global and regional presence through strategic acquisitions and mergers, and operational expansion.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-771

Key Takeaways of Ophthalmic Diagnostic Equipment Market Study

  • The optical coherence tomography (OCT) held the largest share in the global ophthalmic diagnostic equipment market in 2019
  • North America and Europe are expected to hold close to 30% of the global ophthalmic diagnostic equipment market in 2020 and the trend is expected to continue In the forecast period
  • Asia Pacific expected to witness an exponential growth in the forecast period

“Increasing eye-related disorders coupled with market players focusing on technologically advanced ophthalmic diagnostic equipment are expected to substantiate the global ophthalmic diagnostic equipment market”, says FMI analyst.

Expansion and Visibility: Indigenous Strategies for Market Players

The ophthalmic diagnostic equipment market players are focusing on qualitative expansion and visibility to sustain their foothold in the ophthalmic diagnostic equipment market. Some of the steps taken on this count include:

  • In June 2020, IBM Watson partnered with Japan-based Topcon Corporation in order to fast-track the development of products and services that improve the diagnosis, and treatment of eye disease, ultimately improving access for better patient care.
  • In June 2020, Essilor collaborated with Michelin for jointly launching an UN-certified awareness campaign named “Together for safe mobility: Check your vision, check your tires”. The basic objective is to throw light on good vision apart from good tires. This campaign is likely to increase the demand for ophthalmic diagnostic equipment worldwide as UN has officially recommended road safety goals at a global level.
  • Ellex is working in close collaboration with the ophthalmic physicians across the globe regarding minimally invasive options for treatment of glaucoma.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-771

Key Segment

By Product Type

  • Fundus Cameras
  • Retinal Ultrasound Imaging Systems
  • Refractors
  • Slit Lamps
  • Perimeters
  • Ophthalmoscopes
  • Tonometer
  • Optical Coherence Tomography (OCT)
  • Corneal Topography Systems

By End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-771

By Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Automated Suturing Devices Market is poised to expand at over 7.3% CAGR between 2022 and 2031

Surging adoption of minimally invasive procedures due to the rising prevalence of cardiovascular disease and rising incidents leading to trauma and open surgeries is augmenting the growth of automated suturing devices market.

According to Future Market Insights, the global automated suturing devices is poised to expand at a CAGR of 7.3% to reach a valuation of approx. US$ 473 million through 2021 and beyond.

Increasing research & development for advanced automated suturing devices due to the rising adoption of minimally invasive procedure is anticipated to accelerate the demand across countries such as U.S., Japan, India, China and UK.

Automated Suturing Devices Market Key Highlights from Report

  • [257 Pages Report] How will the automated suturing devices market grow in the forecast period of 2021 and 2031?According to FMI, the global automated suturing devices market is poised to expand at over 7.3% CAGR between 2021 and 2031.
  • Which is the most lucrative automated suturing devices market?According to FMI, North America is expected to be the most lucrative region over the forecast period of 2021-2031. Within North America, the U.S. is expected to account for maximum sales.
  • Who is the leading end user of automated suturing devices?Hospitals are expected to emerge as the leading end user in the automated suturing devices market.
  • Which are the prominent automated suturing devices market players?Medtronic Plc., Boston Scientific, C. R. Bard, Inc., Apollo Endosurgery, EndoEvolution, LLC, LSI Solutions, Inc. and SuturTek Inc. are some prominent players operating in the global automated suturing devices market.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-579

automated suturing devices market characteristics and attributes with regional relevence, 2021-2031

Use of automated suturing devices in minimal invasive surgeries, open surgical procedures and major trauma cases that require surgery is expected to drive the market across Asia Pacific excluding Japan (APEJ).

Rising preference for automated suturing devices over conventional ones during laparoscopic surgery is a major factor for market growth. Furthermore, the device is also preferred by procurement teams at hospitals as it’s labelled under “green products”, resulting in considerably less impact on the environment as compared to plastic single-use disposable suturing devices. Thereby, improving the market growth.

Major Key Companies Profiled:

  • Medtronic Plc.
  • Boston Scientific
  • C. R. Bard, Inc.
  • Apollo Endosurgery
  • EndoEvolution, LLC
  • LSI Solutions, Inc.
  • SuturTek Inc.

Key Takeaways from FMI’s Automated Suturing Devices Market Study

  • By product type, disposable automated suturing devices to emerge as lucrative segment through 2021
  • Increasing application in minimally invasive surgeries to stimulate suturing devices sales
  • The U.S. is expected to experience noteworthy expansion amid robust presence of regional suture devices manufacturers, experiencing 1.9x growth
  • India and China are expected to offer lucrative opportunities across South Asia & East Asia
  • Japan is expected to register a stellar growth on the back of rising adoption of minimally invasive procedures
  • Growing cases of gastrointestinal diseases to widen automated suturing devices adoption across Germany

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-579

Competitive Landscape

Medtronic Plc., Boston Scientific, C. R. Bard, Inc., Apollo Endosurgery, EndoEvolution, LLC, LSI Solutions, Inc. and SuturTek Inc. are some prominent players operating in the automated suturing devices market.

Product development and innovation of new devices coupled with strategic mergers and acquisition remains the core strategy for the leading players to maintain a strong foothold in the industry.

In December 2019, for instance, a global leading player, Advanced Medical Solutions Group PLC, manufacturer of tissue adhesives, sutures, hemostats, and internal fixation devices, announced the acquisition of Biomatlante, a developer of synthetic bone graft technologies.

In September 2019, another leading player, Apollo Endosurgery, Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Polypropylene Suture-Anchor Assembly for the use with the Over Stitch Endoscopic Suturing Systems.

Furthermore, in June 2018, Apollo Endosurgery, Inc. received Special 510(k) clearance from the U.S. Food and Drug Administration for Over Stitch Sx Endoscopic Suturing System. The endoscopic suturing systems allowed physicians to place full-thickness sutures from a flexible endoscope in endoscopic surgery.

More Insights on the Global Automated Suturing Devices Market

In its latest report, FMI offers an unbiased analysis of the global automated suturing devices market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (disposable and reusable), application type (minimally invasive surgeries, open surgeries, and trauma)  across seven major regions (North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa)

Key Segments Covered

Product

  • Reusable Automated Suturing Devices
  • Disposable Automated Suturing Devices

Applications

  • Minimally Invasive Surgeries
  • Open Surgeries
  • Trauma Cases

End Use

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

Region

  • North America (US and Canada)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Western Europe (Germany, France, Spain, UK,)
  • Eastern Europe (Bulgaria, Croatia, Russia, Czech Republic)
  • Asia Pacific Excluding Japan (India, China, Vietnam, Australia and Others)
  • Japan
  • Middle East & Africa (GCC, South Africa, Turkey and Rest of MEA)

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-579

Pharmacovigilance Market Key Players – F. Hoffmann- La Roche, GlaxoSmithKline Plc., Covance Inc., ICON Plc. and iGATE Corporation among

ESOMAR-certified company Future Market Insights (FMI) has published a report on the global pharmacovigilance market for the forecast period 2021-2031. According to the report, the market is poised to reach new heights, as pharmaceutical companies scramble to introduce new drug candidates for multiple ailments, which will result in an increase in clinical trials.

As per FMI’s analysis, the market is expected to register double-digit growth, experiencing an impressive CAGR throughout the forecast period. Historically, the market posted credible gains, surpassing US$ 6 billion in 2020, expanding at a CAGR of over 14%. Growth prospects were further heightened during the COVID-19 pandemic, as the scramble for new treatment approaches is prompting pharmaceutical companies to initiate clinical trials for the same.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1107

Prominent pharmaceutical companies are forging long-term partnerships and service agreements with contract research organizations and business processing outsourcing units to enhance existing pharmacovigilance operations by virtue of cost reduction from drug delivery to post-marketing approvals. In April 2021, Thermo Fisher Scientific Inc. announced its plans to acquire Pharmaceutical Product Development (PPD) Inc. for a purchase price of US$ 17.4 billion, which will help enhance the latter’s pharmacovigilance portfolio expansion.

Key Takeaways from FMI’s Pharmacovigilance Market Study

  • By phase of drug development, stage IV clinical trials pharmacovigilance solutions account for over 3 out of 4 applications
  • Based on method type, targeted spontaneous reporting to make maximum use of pharmacovigilance solutions
  • By service provider type, contract outsourcing to generate almost two out of five pharmacovigilance solutions uptake
  • US experiencing robust pharmacovigilance solutions providers presence amid prevalence of good PV practices
  • Forthcoming clinical trials for numerous drug candidates through 2021 to widen UK’s growth prospects
  • India to emerge as an emerging pharmacovigilance hub amid growing trends of medical operations outsourcing
  • China to experience growth on the back of recent amendments to render pharmacovigilance implementation stronger

Key Players:

  • Accenture Plc.
  • Bristol-Myers Squibb
  • Clinquest Group B.V.
  • Cognizant Technology Solutions
  • Covance Inc
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc.
  • ICON Plc
  • iGATE Corporation
  • iMED Global Corporation
  • inVentiv Health Inc.
  • Novartis AG
  • PAREXEL International Corporation
  • Pfizer Inc.
  • Pharmaceutical Product Development LLC. (PPD)
  • PRA Health Sciences Inc.
  • Quintiles Transnational Holdings Inc.
  • Sanofi SA
  • Synowledge LLC
  • Wipro Ltd.

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-1107

Competitive Landscape

Prominent pharmacovigilance solutions providers are relying on collaborating with prominent biopharmaceutical and pharmaceutical companies to offer their digital solutions to facilitate effective patient care solutions. Also, offering advanced solutions is another prominent strategy. Some prominent faces include F. Hoffmann- La Roche, GlaxoSmithKline Plc., Covance Inc., ICON Plc. and iGATE Corporation among others.

Covance Inc. is a prominent pharmacovigilance solutions providing, offering end-to-end PV services spanning clinical and post-marketing phases from medical contract centers to ICSRs to medical reviews to electronic regulatory submissions. The system helps track weekly, daily and monthly metrics for quality, productivity and efficiency.

In April 2020, ICON Plc. initiated efforts to enhance pharmacovigilance practices, considering the onset of COVID-19. A webinar conducted on this issue by the company called for key pharmaceutical companies to automate their workflows by installing proactive and dedicated intelligence processes, forging detailed business and continuity plans and a virtually globally distributed footprint.

Pharmacovigilance Market – Key Segments Covered

Phase of Drug Development

  • Preclinical Studies
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Type of Methods

  • Spontaneous Reporting
  • Intensified ADR Reporting
  • Targeted Spontaneous Reporting
  • Cohort Event Monitoring
  • EHR Mining

Service Type Provider

  • In-house Pharmacovigilance
  • Contract Outsourcing

Geography

  • North America (US and Canada)
  • Europe (Germany, UK, France, Italy, Spain, Russia and Rest of Europe)
  • Asia-Pacific (China, India, ASEAN, Japan and Rest of APAC)
  • Latin America (Brazil, Mexico and Rest of LATAM)
  • Middle East & Africa (GCC, South Africa and Rest of MEA)

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1107